Half the workd’s population is at risk of malaria which is responsable for closet o 800,000 deaths each year, most of whom are children under five in sub-Saharan Africa. Results of trials with GlaxoSmithKline´s (GSK) RTS,S test vaccine show that an effective vaccine is a stage nearer.